Last reviewed · How we verify
NCT06989931
Intracranial Distal Access Catheter in Neurointerventional Therapy
trial testing Intracranial Distal Access Catheter in Acute Ischemic Stroke in 114 participants. Completed in 1 March 2024.
1 March 2024
Quick facts
| Lead sponsor | MicroPort NeuroTech Co., Ltd. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 114 |
| Start date | 7 December 2023 |
| Primary completion | 1 March 2024 |
| Estimated completion | 1 March 2024 |
| Sites | 6 locations across China |
Drugs / interventions tested
- Intracranial Distal Access Catheter
Conditions studied
- Acute Ischemic Stroke — all drugs for Acute Ischemic Stroke →
- Intracranial Aneurysms — all drugs for Intracranial Aneurysms →
Sponsor
MicroPort NeuroTech Co., Ltd.
Who can join
Adults 18 to 80, any sex, with Acute Ischemic Stroke or Intracranial Aneurysms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study objective is to evaluate the safety and effectiveness of Intracranial Distal Access Catheter in neurointerventional therapy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06989931
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Ischemic Stroke
Currently open trials in the same condition.
- NCT07115940 — Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours · NA · recruiting
- NCT07404852 — Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemi · NA · recruiting
- NCT07361302 — A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Pe · Phase 3 · recruiting
- NCT07436156 — SUMMIT RISE Study of Acute Ischemic Stroke Patients · Phase 4 · recruiting
- NCT07203625 — Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours · Phase 4 · recruiting
Other MicroPort NeuroTech Co., Ltd. trials
Trials by the same sponsor.
- NCT06925971 — A Randomized Trial of the Rapamycin Target Eluting Stent for the Treatment of Symptomatic Cerebral Artery Atheroscleroti · Phase 3 · not yet recruiting
- NCT06843616 — A PILOT TRIAL of a DISPOSABLE INTRACEREBRAL ASPIRATION ENDOSCOPE for the TREATMENT of INTRACEREBRAL HEMATOMA（FAST-HET） · NA · recruiting
- NCT07314047 — The Liquid Embolic Agent for the Treatment of Brain Arteriovenous Malformation · NA · recruiting
- NCT06683118 — Registration Trial of the Drug-coated Balloon for the Symptomatic Cerebral Atherosclerotic Stenosis · NA · enrolling by invitation
- NCT06466564 — Bioabsorbable/Nufairy Coil Application Trial in China · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06989931 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by MicroPort NeuroTech Co., Ltd.
- Last refreshed: 25 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06989931.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing